A University of Otago professor whose research into stomach
cancer has saved lives worldwide, has been presented with a
Prof Parry Guilford received the Beaven Medal from the Health
Research Council of New Zealand at a ceremony in Queenstown
The medal recognises excellence in translating research into
clinical practice. Prof Guilford's research included playing
a key role in developing non-invasive bladder cancer
diagnostic tool Cxbladder, which is being sold by Dunedin
company Pacific Edge.
The test was now being commercialised in New Zealand,
Australia and the United States.
As co-founder of Pacific Edge Ltd, Prof Guilford pioneered
the test's underpinning methodology and he remained the
company's chief scientific officer.
Prof Guilford's research on hereditary diffuse gastric
cancer, an inherited condition associated with an increased
risk of stomach cancer, had saved lives worldwide.
His work on HDGC meant members of families with a history of
stomach cancer could now undergo a simple genetic test to
determine their individual risk.
This meant family members who had a negative test no longer
had to live with the fear of getting the disease, while those
who tested positive could receive the necessary life-saving
Prof Guilford told the Otago Daily Times yesterday he
appreciated the recognition, but it was seeing the results of
his research, and not awards, that motivated him.
It also felt ''a bit strange'' receiving the award when the
research was the result of work put in by a team of
The award would be''useful'' when it came to attracting
research grants, he said.
HRC board chairman Sir Robert Stewart said the review panel
was unanimous in its decision to award the medal to Prof